4th Quarter - Report — ELEKTA, INC. for ELEKTA, INC. (2015)

Firm

ELEKTA, INC.

Client

ELEKTA, INC.

Income

—

Expenses

$160,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to oncology treatment products and services; Issues pertaining to the medical device excise tax [Consolidated Appropriations Act 2016 (HR 2029)]

Lobbyist	Covered position, as disclosed
CARA SANTILLO	—
ROBERT D THOMAS	—

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2029 (114th)

Medicare/Medicaid MMM

Issues related to oncology treatment products and services

Lobbyist	Covered position, as disclosed
CARA SANTILLO	—
ROBERT D THOMAS	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.